Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: Association with enhanced serum and glucocorticoid- regulated kinase-1 expression

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 1, 2011, Pages 114-121

  Martín Fernández, Beatriz ^a   De Las Heras, Natalia ^a   Miana, María ^a   Ballesteros, Sandra ^a   Delgado, Carmen ^a,b   Song, Su ^c   Hintze, Thomas ^c   Cachofeiro, Victoria ^a   Lahera, Vicente ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Aldosterone; cardiac hypertrophy; fibrosis; inflammation; oxidation; SGK 1

Indexed keywords

ALDOSTERONE; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GLUCOCORTICOID REGULATED KINASE 1; INTERLEUKIN 1BETA; MESSENGER RNA; METALLOPROTEINASE INHIBITOR; MINERALOCORTICOID RECEPTOR; PHOSPHOTRANSFERASE; SODIUM CHLORIDE; SPIRONOLACTONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA RHYTHM; BLOOD LEVEL; CONNECTIVE TISSUE; DIASTOLIC BLOOD PRESSURE; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; MALE; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; TISSUE GROWTH; TUMOR NECROSIS;

ALDOSTERONE; ANIMALS; BLOOD PRESSURE; FIBROSIS; HEART; IMMEDIATE-EARLY PROTEINS; INTERLEUKIN-1; MALE; MATRIX METALLOPROTEINASE 2; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; PHOSPHOTRANSFERASES; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; RECEPTORS, MINERALOCORTICOID; SODIUM CHLORIDE; SPIRONOLACTONE; SYSTOLE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78951469092     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31820088ca     Document Type: Article

References (66)

1. Cachofeiro V, Miana M, de Las HN, et al. Aldosterone and the vascular system. J Steroid Biochem Mol Biol. 2008;109:331-335.
2. Blanco-Rivero J, Cachofeiro V, Lahera V, et al. Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension. 2005;46:107-112.
3. Arima S, Kohagura K, Xu HL, et al. Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole. Hypertension. 2004;43:352-357.
4. Mihailidou AS, Mardini M, Funder JW. Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C. Endocrinology. 2004;145:773-780.
5. Conn JW, Hinerman DL. Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies. Metabolism. 1977;26:1293-1307.
6. Yoshida K, Kim-Mitsuyama S, Wake R, et al. Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. Hypertens Res. 2005;28:447-455.
7. Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med. 1992;120:893-901.
8. Rocha R, Rudolph AE, Frierdich GE, et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2002;283:H1802-H1810.
9. Sun Y, Zhang J, Lu L, et al. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol. 2002;161:1773-1781.
10. Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res. 1992;26:671-677.
11. Robert V, Silvestre JS, Charlemagne D, et al. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension. 1995;26: 971-978.
12. Sun Y, Ramires FJ, Weber KT. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res. 1997; 35:138-147.
13. Lijnen P, Petrov V. Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol. 2000;32:865-879.
14. Benitah JP, Vassort G. Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes. Circ Res. 1999;85:1139-1145.
15. Bers DM, Guo T. Calcium signaling in cardiac ventricular myocytes. Ann N Y Acad Sci. 2005;1047:86-98.
16. Perrier E, Kerfant BG, Lalevee N, et al. Mineralocorticoid receptor antagonism prevents the electrical remodeling that precedes cellular hypertrophy after myocardial infarction. Circulation. 2004;110:776-783.
17. Iglarz M, Touyz RM, Viel EC, et al. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system. Am J Hypertens. 2004;17:597-603.
18. Rohini A, Agrawal N, Koyani CN, et al. Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res. 2010;61:269-280.
19. Sun Y, Zhang J, Lu L, et al. Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart. J Lab Clin Med. 2004;143:41-51.
20. Rocha R, Martin-Berger CL, Yang P, et al. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology. 2002;143:4828-4836.
21. Kobayashi T, Deak M, Morrice N, et al. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoidinduced protein kinase. Biochem J. 1999;344(pt 1):189-197.
22. + channel alpha, beta, gamma-ENaC. Pflugers Arch. 2003;445:693-696.
23. Bhargava A, Fullerton MJ, Myles K, et al. The serum- and glucocorticoidinduced kinase is a physiological mediator of aldosterone action. Endocrinology. 2001;142:1587-1594.
24. Fejes-Toth G, Pearce D, Naray-Fejes-Toth A. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc Natl Acad Sci U S A. 1998;95:2973-2978.
25. Trapp T, Holsboer F. Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping. Biochem Biophys Res Commun. 1995;215:286-291.
26. Virbasius JV, Song X, Pomerleau DP, et al. Activation of the Akt-related cytokine-independent survival kinase requires interaction of its phox domain with endosomal phosphatidylinositol 3-phosphate. Proc Natl Acad Sci U S A. 2001;98:12908-12913.
27. BelAiba RS, Djordjevic T, Bonello S, et al. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circ Res. 2006;98:828-836.
28. Busjahn A, Aydin A, Uhlmann R, et al. Serum- and glucocorticoidregulated kinase (SGK1) gene and blood pressure. Hypertension. 2002; 40:256-260.
29. Kumar JM, Brooks DP, Olson BA, et al. Sgk, a putative serine/threonine kinase, is differentially expressed in the kidney of diabetic mice and humans. J Am Soc Nephrol. 1999;10:2488-2494.
30. Zhao X, Wu N, Deng M, et al. An improved method of left ventricular catheterization in rats. Physiol Meas. 2006;27:N27-N33.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
32. Farquharson CA, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation. 2000;101:594-597.
33. Parrinello G, Di PP, Licata G, et al. Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail. 2009;15: 864-873.
34. Fraccarollo D, Galuppo P, Schraut S, et al. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension. 2008;51:905-914.
35. Kieval RS, Bloch RJ, Lindenmayer GE, et al. Immunofluorescence localization of the Na-Ca exchanger in heart cells. Am J Physiol. 1992; 263:C545-C550.
36. Martin-Fernandez B, Miana M, de Las HN, et al. Cardiac L-type calcium current is increased in a model of hyperaldosteronism in the rat. Exp Physiol. 2009;94:675-683.
37. Brunaud L, Germain A, Zarnegar R, et al. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery. 2009;146:1035-1041.
38. Fujita T, Palmieri GM. Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab. 2000;18:109-125.
39. Kamalov G, Ahokas RA, Zhao W, et al. Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am J Physiol Heart Circ Physiol. 2010;298:H385-H394.
40. Christ M, Meyer C, Sippel K, et al. Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C alpha. Biochem Biophys Res Commun. 1995;213:123-129.
41. 2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology. 2005;146:973-980.
42. Brown NJ. Eplerenone: cardiovascular protection. Circulation. 2003;107: 2512-2518.
43. Mano A, Tatsumi T, Shiraishi J, et al. Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. Circulation. 2004;110:317-323.
44. Wehling M, Ulsenheimer A, Schneider M, et al. Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging. Biochem Biophys Res Commun. 1994;204:475-481.
45. Mill JG, Milanez MC, de Resende MM, et al. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats. Clin Exp Pharmacol Physiol. 2003;30:739-744.
46. Rocha R, Stier CT Jr, Kifor I, et al. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology. 2000;141:3871-3878.
47. Brilla CG, Zhou G, Matsubara L, et al. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809-820.
48. Liu SL, Schmuck S, Chorazcyzewski JZ, et al. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3- kinase-dependent nitric oxide synthase activation. Circulation. 2003;108: 2400-2406.
49. Stockand JD, Meszaros JG. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol. 2003;284:H176-H184.
50. 2+ in vascular smooth muscle cells. Circ Res. 1995;76:973-979.
51. Zhou G, Kandala JC, Tyagi SC, et al. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem. 1996;154:171-178.
52. Juknevicius I, Segal Y, Kren S, et al. Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Renal Physiol. 2004;286: F1059-F1062.
53. Sun GP, Kohno M, Guo P, et al. Involvements of Rho-kinase and TGFbeta pathways in aldosterone-induced renal injury. J Am Soc Nephrol. 2006;17:2193-2201.
54. Yu HC, Burrell LM, Black MJ, et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation. 1998;98: 2621-2628.
55. Kornel L, Ramsay C, Kanamarlapudi N, et al. Evidence for the presence in arterial walls of intracellular-molecular mechanism for action of mineralocorticoids. Clin Exp Hypertens A. 1982;4:1561-1582.
56. Koitabashi N, Arai M, Kogure S, et al. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension. 2007;49:1120-1127.
57. Lee YS, Kim JA, Kim KL, et al. Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes. J Korean Med Sci. 2004;19:805-811.
58. Vallon V, Wyatt AW, Klingel K, et al. SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. J Mol Med. 2006;84: 396-404.
59. Ide T, Tsutsui H, Kinugawa S, et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res. 1999;85:357-363.
60. Kinugawa S, Tsutsui H, Hayashidani S, et al. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res. 2000;87:392-398.
61. Siwik DA, Chang DL, Colucci WS. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res. 2000;86: 1259-1265.
62. Rude MK, Duhaney TA, Kuster GM, et al. Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes. Hypertension. 2005;46:555-561.
63. Nishiyama A, Yao L, Nagai Y, et al. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension. 2004;43: 841-848.
64. 2 in peripheral blood mononuclear cells. Circulation. 2005;111: 51-57.
65. Stevens VA, Saad S, Poronnik P, et al. The role of SGK-1 in angiotensin IImediated sodium reabsorption in human proximal tubular cells. Nephrol Dial Transplant. 2008;23:1834-1843.
66. Lang F, Bohmer C, Palmada M, et al. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev. 2006;86:1151-1178.